Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PK68 is an effective and selective inhibitor of type II receptor-interacting kinase 1 (RIPK1, IC50 = 90 nM). PK68 can be used for research on the treatment of inflammatory disorders and cancer metastasis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 90.00 | |
5 mg | In stock | $ 178.00 | |
10 mg | In stock | $ 289.00 | |
25 mg | In stock | $ 547.00 | |
50 mg | In stock | $ 789.00 | |
100 mg | In stock | $ 1,080.00 | |
500 mg | In stock | $ 2,190.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 198.00 |
Description | PK68 is an effective and selective inhibitor of type II receptor-interacting kinase 1 (RIPK1, IC50 = 90 nM). PK68 can be used for research on the treatment of inflammatory disorders and cancer metastasis. |
Targets&IC50 | RIPK1:90 nM |
Molecular Weight | 424.52 |
Formula | C22H24N4O3S |
CAS No. | 2173556-69-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (58.89 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PK68 2173556-69-7 Apoptosis NF-Κb Others RIP kinase Inhibitor inflammatory RIPK oral Receptor-interacting protein kinases cancer type II inhibitor PK 68 PK-68 inhibit receptor-interacting kinase 1 (RIPK1) TNF inhibitor